Search research articles
Contact Us
Filters
Showing results (1-10 of 95) with videos related to
Page
of 10
Sort By:
Seminars in Liver Disease
|
May 5, 2006
Serological and molecular diagnosis
Scott Bowden
Hepatology (Baltimore, Md.)
|
March 29, 2012
Hepatitis B surface antigen quantification: not what it seems on the surface
Stephen Locarnini, Scott Bowden
Clinics in Liver Disease
|
July 20, 2010
Drug resistance in antiviral therapy
Stephen Locarnini, Scott Bowden
Current Opinion in Investigational Drugs (London, England : 2000)
|
August 4, 2009
Hepatitis B: the case for combination therapy
Scott Bowden, Tim Shaw
Gastroenterology
|
November 28, 2002
Chemotherapy for hepatitis B: new treatment options necessitate reappraisal of traditional endpoints
Tim Shaw, Scott Bowden, Stephen Locarnini
Journal of Hepatology
|
March 29, 2003
Lamivudine resistant occult HBV: implications for public health?
Scott Bowden, Angeline Bartholomeusz, Stephen Locarnini
Future Microbiology
|
July 31, 2007
Chronic hepatitis C virus infection: genotyping and its clinical role
D Scott Bowden, Mark D Berzsenyi
Gastroenterology
|
December 31, 2003
Rescue therapy for drug resistant hepatitis B: another argument for combination chemotherapy?
Tim Shaw, Scott Bowden, Stephen Locarnini
Hepatology International
|
August 12, 2009
New developments in HBV molecular diagnostics and quantitative serology
D Scott Bowden, Alex J Thompson
Methods in Molecular Medicine
|
February 6, 2004
Quantification of HBV covalently closed circular DNA from liver tissue by real-time PCR
Scott Bowden, Kathy Jackson, Margaret Littlejohn, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 95) with videos related to
Sort By:
Page
of 10
Seminars in Liver Disease
|
May 5, 2006
Serological and molecular diagnosis
Scott Bowden
Hepatology (Baltimore, Md.)
|
March 29, 2012
Hepatitis B surface antigen quantification: not what it seems on the surface
Stephen Locarnini, Scott Bowden
Clinics in Liver Disease
|
July 20, 2010
Drug resistance in antiviral therapy
Stephen Locarnini, Scott Bowden
Current Opinion in Investigational Drugs (London, England : 2000)
|
August 4, 2009
Hepatitis B: the case for combination therapy
Scott Bowden, Tim Shaw
Gastroenterology
|
November 28, 2002
Chemotherapy for hepatitis B: new treatment options necessitate reappraisal of traditional endpoints
Tim Shaw, Scott Bowden, Stephen Locarnini
Journal of Hepatology
|
March 29, 2003
Lamivudine resistant occult HBV: implications for public health?
Scott Bowden, Angeline Bartholomeusz, Stephen Locarnini
Future Microbiology
|
July 31, 2007
Chronic hepatitis C virus infection: genotyping and its clinical role
D Scott Bowden, Mark D Berzsenyi
Gastroenterology
|
December 31, 2003
Rescue therapy for drug resistant hepatitis B: another argument for combination chemotherapy?
Tim Shaw, Scott Bowden, Stephen Locarnini
Hepatology International
|
August 12, 2009
New developments in HBV molecular diagnostics and quantitative serology
D Scott Bowden, Alex J Thompson
Methods in Molecular Medicine
|
February 6, 2004
Quantification of HBV covalently closed circular DNA from liver tissue by real-time PCR
Scott Bowden, Kathy Jackson, Margaret Littlejohn, et al.
Page
of 10